Varex Imaging (NASDAQ:VREX) First Quarter 2025 Results

Key Financial Results

• Revenue: US$199.8m (up 5.2% from 1Q 2024).
• Net loss: US$300.0k (loss narrowed by 40% from 1Q 2024).
• US$0.007 loss per share (improved from US$0.012 loss in 1Q 2024).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Varex Imaging EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates by 79%.

Looking ahead, revenue is forecast to grow 2.2% p.a. on average during the next 2 years, compared to a 7.8% growth forecast for the Medical Equipment industry in the US.

Performance of the American Medical Equipment industry.

The company's shares are down 11% from a week ago.

Risk Analysis

Before you take the next step you should know about the 1 warning sign for Varex Imaging that we have uncovered.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.